Phase 1 Dyspareunia Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Not Yet Recruiting
Phase 1
A study in healthy women comparing two topical gels (Mi-Gel® and estriol gel) applied to the vulva twice daily over 6 consecutive days in two seperate applicaton periods.
VestibulitisVulvodyniaDyspareunia
Zenith Technology Corporation Limited34 enrolled1 locationACTRN12625001284459
Not Yet Recruiting
Phase 1
A pivotal study in healthy women comparing Mi-Gel® and amitriptyline gel applied topically for 6 consecutive days.
VestibulitisVulvodyniaDyspareunia
Zenith Technology Corporation Limited24 enrolled1 locationACTRN12625000939493
Completed
Phase 1
A study in healthy women comparing Mi-Gel® and estriol gel applied topically for 6 consecutive days.
VestibulitisVulvodyniaDyspareunia
Zenith Technology Corporation Limited8 enrolled1 locationACTRN12625000393459
Completed
Phase 1
A study in healthy women comparing Mi-Gel® and amitriptyline gel applied topically for 6 consecutive days.
VestibulitisVulvodyniaDyspareunia
Zenith Technology Corporation Limited8 enrolled1 locationACTRN12625000315415